Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear

  title={Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear},
  author={Ingrid Torjesen},
  • I. Torjesen
  • Published 29 November 2021
  • Political Science
  • BMJ
To slow the spread of the variant the UK government has announced that masks are again to become compulsory on public transport and in shops and schools, all contacts of people with a case of omicron will be required to isolate for 10 days, and all travellers entering the countrywill have to take aPCR test twodays later and to self-isolate until they receive a negative result. On 29 November the government was expected to announce that the vaccine booster programme would be expanded to people… 
The Emergence of Omicron: Challenging Times Are Here Again!
  • T. Singhal
  • Medicine
    Indian Journal of Pediatrics
  • 2022
The direct effects of omicron on children are expected to be mild like with the previous variants, however, the indirect effects on child mental, physical, and social health may be considerable owing to school closures, missed vaccinations, neglect of other diseases, etc.
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
In this overview, various drugs and vaccines used to counter this pandemic are highlighted along with their reported side effects and the preliminary data for the novel VOC “Omicron” are discussed with the existing animal models.
COVID-19 vaccine coverage and the necessity of its urgent development towards Omicron the new SARS CoV-2 B.1.1. 529 variant
The Omicron variant is the most diverging variety discovered in substantial numbers so far during the pandemic, raising significant concerns that it may be associated with significant reductions in vaccination efficacy and an increased risk of reinfections.
Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
This review looks into the efficacy and safety of COVID-19 vaccination booster to guide clinical decisions on when and who to receive booster vaccination.
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments
Compared with the Delta variant, infection with the Omicron variant in patients in the ED had different clinical and biological patterns and was associated with better in-hospital outcomes, including higher survival.
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
This work investigated whether Omicron escapes antibody neutralization elicited by the Pfizer BNT162b2 mRNA vaccine and whether the virus still requires binding to the ACE2 receptor to infect cells, and tested the ability of plasma from BNT 162b2 vaccinated study participants to neutralize Omicrons versus ancestral D614G virus in a live virus neutralization assay.
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
This review focused on the genomics, transmission, and effectiveness of vaccines against the Omicron variant, which will be helpful for further investigation of a new variant of SARS‐CoV‐2.
BA.1 Omicron Variant of SARS-CoV-2: First Case Reported in Calabria Region, Italy
The first case of the Omicron genetic lineage BA.1.529 (Omicron) variant of SARS-CoV-2 spread rapidly worldwide is described in this region, with a physician who traveled to Johannesburg and returned to Reggio Calabria and reported suffering from a cold and sore throat.
Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data
Omicron SAR was higher (41%) than Delta (35%), likely due to immune evasion, and booster dose reduces risk of infection but has limited effect on preventing Omicron transmission.